BOLT
Bolt Biotherapeutics
NASDAQ: BOLT · HEALTHCARE · BIOTECHNOLOGY
$4.87
+2.21% today
Updated 2026-04-30
Market cap
$9.28M
P/E ratio
—
P/S ratio
1.21x
EPS (TTM)
$-17.85
Dividend yield
—
52W range
$4 – $9
Volume
0.0M
Bolt Biotherapeutics (BOLT) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-9.87M | $-26.34M | $-47.31M | $-57.07M | $-76.50M | $-69.53M | $-61.29M | $-39.85M |
| Capital expenditures | $290000.00 | $508000.00 | $3.26M | $2.34M | $1.95M | $206000.00 | $41000.00 | $72000.00 |
| Depreciation | — | — | — | — | — | — | — | — |
| Stock-based comp | $123000.00 | $508000.00 | $1.42M | $8.50M | $9.58M | $9.22M | $7.41M | $2.78M |
| Free cash flow | $-10.16M | $-26.85M | $-50.57M | $-59.40M | $-78.46M | $-69.73M | $-61.33M | $-39.92M |
| Investing cash flow | — | — | — | — | — | — | — | — |
| Financing cash flow | — | — | — | — | — | — | — | — |
| Dividends paid | — | — | — | — | — | — | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | — | — | — | — | — | — |